Director, AI Small Molecule Drug Design

<div><div style="width:6.6493in;"><div style="width:6.6493in;"><span style="font-size:14px;"><span style="font-family:Arial, Helvetica, sans-serif;">SystImmune is a leading and well-funded clinical-stage biopharmaceutical company located in Redmond, WA and Princeton, NJ. It specializes in developing innovative cancer treatments using its established drug development platforms, focusing on bi-specific, multi-specific antibodies, and antibody-drug conjugates (ADCs). SystImmune has multiple assets in various stages of clinical trials for solid tumor and hematologic indications. Alongside ongoing clinical trials. SystImmune has a robust preclinical pipeline of potential cancer therapeutics in the discover and IND-enabling stages, representing cutting-edge biologics development. We offer an opportunity for you to learn and grow while making significant contributions to the company's success.<br>&#160;<br><span style="line-height:115%;">We&#8217;re hiring a Director to define, build, and lead our AI-enabled small molecule design function. This is a hands-on, individual-contributor-heavy role at the outset, where you will personally own strategy and execution, building core design workflows and delivering high-quality candidate molecules before scaling a team around you. As the founding technical leader, you will collaborate closely with chemists biologists, and computational scientists to integrate AI-driven design into end-to-end drug discovery efforts at SystImmune.</span><br>&#160;<br>This position is located in Redmond, WA and requires an onsite presence.<br><br><strong><span style="line-height:115%;">Key Responsibilities</span></strong></span></span>